Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AbriladaTM, accretion, aflibercept, AI, AmjevitaTM, atezolizumab, ATM, autoinjector, avelumab, Bavencio, BeiGene, biomedical, book, comprised, Connecticut, counterparty, Cowen, custodian, CyltezoTM, deposit, deposited, donated, donation, durvalumab, EMD, FDIC, feasible, forfeiture, geographical, GlaxoSmithKline, HadlimaTM, hosting, Hulio, HyrimozTM, Imfinzi, immuno, insignificant, Intelligence, Iowa, Jemperli, Keytruda, Klinge, Libtayo, lingering, minimize, modification, mutual, nivolumab, Opdivo, payroll, pembrolizumab, people, ProBioGen, purpose, regularly, reject, relaxed, resurgence, Roche, Sanofi, segregation, Serono, Silicon, sintilimab, SOFR, Spectrum, stance, sum, supervisory, SusvimoTM, Tecentriq, tighter, Vabysmo, Valley, workforce
Removed:
altered, amelioration, Asian, assist, attributable, bear, booster, borrowing, brother, categorization, cessation, Chairman, concurrently, credited, declining, Delta, discounted, DLOM, drew, Eli, enrollment, ePrivacy, EQRx, Exhibit, expensed, Finnerty, Fujifilm, hourly, inoculated, inpatient, instrument, InteKrin, interactive, Jonathan, Kirin, Kyowa, Lilly, liquid, marketability, mid, migrated, mission, Mitigation, motivation, Mylan, omicron, overnight, paper, partly, prepay, prevention, prioritization, prioritized, qualification, rated, realignment, redeemed, redemption, referenced, refinancing, reluctance, revised, rollout, safest, slightly, subvariant, tracking, Trademark, valuation, variant, vested, wholly, York
Filing tables
Filing exhibits
Related press release
Associated CHRS transcripts
CHRS similar filings
Filing view
External links